CERS vs KEY · rev $201.3M vs P/E 13, rev $7.51B
Cerus Corporation (CERS) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
CERS currently screens at market cap $294.4M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the CERS and KEY stock pages for the full models.
Not investment advice.